SANKYO C22 (Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 20 mg)
Pill with imprint SANKYO C22 is Yellow, Round and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 20 mg. It is supplied by Sun Pharmaceutical Industries Inc..
Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 12.5 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SANKYO C22
- SANKYO C22
- 12.5 mg / 20 mg
- 9.00 mm
- Prescription only
- Drug Class
- Angiotensin ii inhibitors with thiazides
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|57664-0758||Caraco Pharmaceutical Laboratories, Ltd.|
|54868-5170||Physicians Total Care Inc. (repackager)|
|35356-0256||Lake Erie Medical and Surgical Supply (repackager)|
Related Images for "SANKYO C22"
More about hydrochlorothiazide / olmesartan
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 30 Reviews
- Drug class: angiotensin II inhibitors with thiazides
- FDA Alerts (4)
- Other brands
- Benicar HCT
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.